Geathers v. Sanofi Aventis US LLC | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Geathers v. Sanofi Aventis US LLC

Sort by

Viewing results 1‒25 of 30

US & Canadian companies
HP adds activist investor Whitworth to board
...He also has served on the board of Genzyme, the biotech company sold to Sanofi-Aventis this year for more than $20bn....
November 18, 2011
US & Canadian companies
KKR to buy Pfizer’s capsule unit for $2.4bn
...In a research note on Monday, Cowen argued that a number of the large pharmaceutical groups, led by Eli Lilly, Sanofi-Aventis and Pfizer, would be worth more if they divested separable business units, which...
April 4, 2011
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
US & Canadian companies
Valeant’s Cephalon bid portends new era
...Sanofi-Aventis has continued aggressively to acquire others, including ultimately winning support for the takeover of US group Genzyme after raising its bid above $20bn....
April 4, 2011
US & Canadian companies
Eli Lilly joins forces with Boehringer Ingelheim
...Diabetes medications still make up about 17 per cent of Lilly’s $22bn revenues, but in recent years it has lost ground to rivals such as Merck and Sanofi-Aventis....
January 11, 2011
US & Canadian companies
Sanofi steps up Genzyme pursuit
...Sanofi-Aventis stepped up its pursuit of Genzyme on Sunday, outlining publicly its interest in a takeover deal as it inched closer to making a hostile offer for the US biotech company....
August 29, 2010
European companies
V-Zug aims to export domestic expertise
...High factory automation has helped contain V-Zug’s costs, including a smart new computerised logistics centre opened this year. “Productivity is a key success factor for us,” Mr Buhofer says....
July 27, 2010
FT Live
US Decarbonization and Industrial Transition Summit
Securing the resources to build and finance America's clean energy future
Wednesday, 29 MayWashington, D.C., USA
Mergers & Acquisitions
Tokyo’s streets provide real-world test for electric cabs
...In pharmaceuticals, the government engineered the merger between Sanofi and Aventis to create a new champion rather than allow the Swiss Novartis to swallow it up....
April 26, 2010
World
Wall Street falls amid deals
...A study by a British medical journal reported that a blood-thinning pill developed by the company worked better than Plavix, a rival drug made by Sanofi-Aventis....
August 31, 2009
US & Canadian companies
Swine flu vaccine manufacturers gear up
...The World Health Organisation on Monday said that leading vaccine producers including Novartis, GlaxoSmithKline and Sanofi-Aventis had requested “wild type virus” samples of the A (H1N1) virus....
May 11, 2009
Inside EuropeMergers & Acquisitions
Nestlé may likely to end suspense over L’Oréal stake
...Then again, now that the Dutch group has flagged its interest in a takeover, Sanofi-Aventis and its rivals may come back with counter offers....
January 13, 2009
UK retail results
Footsie at highest since February
...Bernstein saw Bristol-Myers Squibb, GlaxoSmithKline and Sanofi Aventis among potential buyers of the franchise....
April 29, 2009
Pharmaceuticals sector
Astrazeneca names new head of US business
...His appointment comes as GlaxoSmithKline also seeks a new US head of operations, following the recent departure of Chris Viehbacher, who takes over as chief executive of Sanofi-Aventis of France at the start...
November 18, 2008
EU energy
Rebound in crude prices bolsters stocks
...Swiss drugmaker Novartis gained 23.7 per cent to SFr59.50 while in France, Sanofi-Aventis climbed 17.2 per cent to €44.44. Germany’s BMW was boosted by an upgrade from Goldman Sachs....
October 17, 2008
US & Canadian companies
Buffett snaps up NRG stake
...Mr Buffett also added to his positions in Ingersoll-Rand, a maker of refrigeration gear, and Sanofi Aventis, the French drugmaker....
August 15, 2008
US downturn
Wall St lower on housing concerns
...Shares in Bristol-Myers Squibb fell 3.3 per cent to $27.59 after reports of a break-down in the merger talks with Sanofi-Aventis ....
February 12, 2007
FT Live
Investing in America
Foreign companies as drivers of US growth, resilience and competitiveness
Tuesday, 10 DecemberHybrid Conference
IPOs
Sanofi buys stake in Czech generic drug maker
...Sanofi-Aventis, the pharmaceutical group formed when Sanofi Synthelabo merged with Aventis in 2004 after the French government intervened to warn off Novartis, bought a 19.6 per cent stake from Warburg Pincus...
March 27, 2006
Mergers & Acquisitions
BP sale continues divestment moves by Kuwaitis
...But Friday’s sale comes after the Kuwait Petroleum Corporation (KPC) last year reduced its 13.5 per cent stake in Aventis following the takeover by Franco-German group Sanofi-Synthelabo....
December 9, 2005
EU energy
Europe eases despite drug strength
...Sanofi-Aventis faces its own court battle over generic competition for its blood-thinning drug Plavix....
December 19, 2005
European banks
Europe retreats amid telecoms concerns
...Novartis fell 1.4 per cent to SFr69.10 amid talk that it was emerging as the leading contender but others rumoured to be interested included Roche , 1.8 per cent higher at SFr224.0, Sanofi-Aventis , 0ff...
December 5, 2005
European banks
European bourses climb to 3½-year highs
...Other gainers included Sanofi-Aventis, up 0.9 per cent at €69.35, and Serono, 0.9 per cent firmer at SFr859....
October 3, 2005
US downturn
Oil and drugs stocks drag on Europe
...Shares in Novo Nordisk retreated 1.5 per cent to DKr323.50, while Novartis fell back 1.1 per cent to SFr61.65, Sanofi-Aventis eased 1.6 per cent to €70.65 and Roche lost 1.1 per cent to SFr173.60....
August 23, 2005
News in-depthThe Big Read
VW cosies up to Porsche
...It follows a bout of economic nationalism in France, where the government last year engineered the takeover of Aventis, the pharmaceuticals company, by rival Sanofi, and the bailout of engineering group...
September 26, 2005
Mergers & Acquisitions
Rumour mill grinds Europe to fresh 3-year high
...Sanofi-Aventis, the drugmaker, announced sales growth of 6.5 per cent in the second quarter, a little below expectations, knocking the shares 0.6 per cent to €70....
July 19, 2005
European banks
Bourses climb to 3-year high
...Sanofi-Aventis, the French drugs group, tumbled 5.4 per cent to €67.30 after it said a generic-drug maker had won a summary judgement in a US court over the patent covering Sanofi’s key Lovenox stroke treatment...
June 16, 2005
Mergers & Acquisitions
European M&A at lowest level since 1994
...Last year's deal value was also boosted by Sanofi-Synthelabo's €66bn hostile bid for rival pharmaceutical company Aventis....
March 2, 2005

Previous pagePage 1 of 2Next page